发明名称 Administration of enoxaparin sodium to patients 75 years and older with ST-segment elevation myocardial infarction
摘要 <p>Methods for treating ST-segment elevation myocardial infarction in a human patient 75 years of age or older. The methods comprise administering a dose of less than 1 mg per kg body weight, about .75 mg per kg of body weight, or .75 mg per kg of body weight of enoxaparin sodium by subcutaneous injection approximately every twelve hours for a therapeutic dosing period. The methods may include fibrinolytic therapy. The treatment methods may be used to prevent one or more of, mortality, myocardial re-infarction, myocardial ischemia, stroke, or severe congestive heart failure. Articles of manufacture for use in connection with treating ST-segment elevation myocardial infarction in a human patient 75 years of age or older are also disclosed. The articles of manufacture comprise enoxaparin sodium, and instructions designed to achieve administration to a patient of a dose of less than 1 mg per kg body weight, about .75 mg per kg of body weight, or .75 mg per kg of body weight of enoxaparin sodium, by subcutaneous injection approximately every twelve hours for a therapeutic dosing period.</p>
申请公布号 EP1598070(A1) 申请公布日期 2005.11.23
申请号 EP20040291119 申请日期 2004.04.30
申请人 AVENTIS PHARMA S.A. 发明人 SANDERINK, GER-JAN C.M.;VETTICADEN, SANTOSH;BACHER, HANS PETER
分类号 A61K31/727;A61P9/10;(IPC1-7):A61K31/727 主分类号 A61K31/727
代理机构 代理人
主权项
地址
您可能感兴趣的专利